Millennium Biltmore Hotel
Los Angeles

Downtown Los Angeles, California


SYMPOSIUM INFORMATION

>General Information
>Faculty
>Program/Schedule
>Accreditatio/CME Surveys
>Registration
>Hotel Reservations

 

Supported by:
GOOD SAMARITAN HOSPITAL
Los Angeles, CA

Officially Endorsed by:
THE HEART FAILURE SOCIETY OF AMERICA

Affiliated With:
INTERNATIONAL ACADEMY OF CARDIOLOGY

Related Conferences:


22nd Annual

Heart Failure 2018
Update on Diagnosis and Therapy
April 21, 2018

ACCREDITATION

This Live activity, 22nd Annual Symposium - Heart Failure 2018, with a beginning date of April 21, 2018 is currently being reviewed for up to TBA Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

IMPORTANT 2017 CME CREDIT NOTICE
CME Certificates will be issued digitally after Speaker and Symposium Surveys are completed. Surveys are accessible after signing in with the email address you submitted during registration.

Surveys will be accessible online the day of the symposium and for 3 weeks following. You must complete the process by May 15, 2017 in order to receive your certificate. Certificates will be available online until November 1, 2018 and are printable directly from the website. Login Required.

 


COURSE DESCRIPTION
T?he 22nd Annual Heart Failure 2018: An Update on Therapy will be held on Saturday, April 21, 2018 at the historic and luxurious Millennium Biltmore hotel in Los Angeles, CA. This year’s program will provide a comprehensive update on the prevention, diagnosis and management of Heart Failure (HF). The program includes lectures presented by experts in the field combined with interactive panel discussions with faculty. The extensive list of topics includes the latest information on the management of hypertension, hypercholesterolemia, pulmonary hypertension, acute and chronic HF, valvular disease, electrolyte abnormalities, amyloidosis and sarcoidosis, stroke prevention and treatment of atrial fibrillation and the use of electrophysiological and cardiac assist devices for the treatment of HF. As in past years, this year’s program was designed to provide a high level and clinically relevant update with the goal of improving the care of patients with heart failure.

PROGRAM OBJECTIVES
Objectives and Needs Assessment will be posting in early November.

TARGET AUDIENCE
The program has been designed to provide cardiologists, internists, primary care physicians, pharmacists, nurses and other healthcare providers with the necessary information to increase knowledge with the goal of improving the care of patients with HF.

FACULTY DISCLOSURE
It is our policy to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. This information is used to plan future activities.